Selected research
Market Structure
Global Tolvaptan Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Tolvaptan Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Tolvaptan Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tolvaptan Tablets include CHIA TAI TIANQING PHARMACEUTICAL GROUP, Jiangsu Hengrui Pharmaceuticals, Chengdu Brilliant Pharmaceutical, Chengdu Baiyu Pharmaceutical, Otsuka Pharmaceutical and Healing Pharma India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Tolvaptan Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Tolvaptan Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Tolvaptan Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tolvaptan Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Tolvaptan Tablets Segment by Company
CHIA TAI TIANQING PHARMACEUTICAL GROUP
Jiangsu Hengrui Pharmaceuticals
Chengdu Brilliant Pharmaceutical
Chengdu Baiyu Pharmaceutical
Otsuka Pharmaceutical
Healing Pharma India
Tolvaptan Tablets Segment by Type
15mg
30mg
Tolvaptan Tablets Segment by Application
Clinic
Hospital
Pharmacy
Tolvaptan Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tolvaptan Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tolvaptan Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tolvaptan Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Tolvaptan Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tolvaptan Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tolvaptan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tolvaptan Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 15mg
- 30mg
Applications
- Clinic
- Hospital
- Pharmacy
Companies covered
- CHIA TAI TIANQING PHARMACEUTICAL GROUP
- Jiangsu Hengrui Pharmaceuticals
- Chengdu Brilliant Pharmaceutical
- Chengdu Baiyu Pharmaceutical
- Otsuka Pharmaceutical
- Healing Pharma India
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Tolvaptan Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Tolvaptan Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Tolvaptan Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Tolvaptan Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Tolvaptan Tablets Market Dynamics
- 2.1 Tolvaptan Tablets Industry Trends
- 2.2 Tolvaptan Tablets Industry Drivers
- 2.3 Tolvaptan Tablets Industry Opportunities and Challenges
- 2.4 Tolvaptan Tablets Industry Restraints
3 Tolvaptan Tablets Market by Manufacturers
- 3.1 Global Tolvaptan Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Tolvaptan Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Tolvaptan Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Tolvaptan Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tolvaptan Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Tolvaptan Tablets Manufacturers, Product Type & Application
- 3.7 Global Tolvaptan Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tolvaptan Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tolvaptan Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Tolvaptan Tablets Tier 1, Tier 2, and Tier 3
4 Tolvaptan Tablets Market by Type
- 4.1 Tolvaptan Tablets Type Introduction
- 4.1.1 15mg
- 4.1.2 30mg
- 4.2 Global Tolvaptan Tablets Sales by Type
- 4.2.1 Global Tolvaptan Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Tolvaptan Tablets Sales by Type (2021-2032)
- 4.2.3 Global Tolvaptan Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Tolvaptan Tablets Revenue by Type
- 4.3.1 Global Tolvaptan Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Tolvaptan Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Tolvaptan Tablets Revenue Market Share by Type (2021-2032)
5 Tolvaptan Tablets Market by Application
- 5.1 Tolvaptan Tablets Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Pharmacy
- 5.2 Global Tolvaptan Tablets Sales by Application
- 5.2.1 Global Tolvaptan Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Tolvaptan Tablets Sales by Application (2021-2032)
- 5.2.3 Global Tolvaptan Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Tolvaptan Tablets Revenue by Application
- 5.3.1 Global Tolvaptan Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Tolvaptan Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Tolvaptan Tablets Revenue Market Share by Application (2021-2032)
6 Global Tolvaptan Tablets Sales by Region
- 6.1 Global Tolvaptan Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Tolvaptan Tablets Sales by Region (2021-2032)
- 6.2.1 Global Tolvaptan Tablets Sales by Region (2021-2026)
- 6.2.2 Global Tolvaptan Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Tolvaptan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Tolvaptan Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Tolvaptan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Tolvaptan Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Tolvaptan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Tolvaptan Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Tolvaptan Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Tolvaptan Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Tolvaptan Tablets Revenue by Region
- 7.1 Global Tolvaptan Tablets Revenue by Region
- 7.1.1 Global Tolvaptan Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Tolvaptan Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Tolvaptan Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Tolvaptan Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Tolvaptan Tablets Revenue (2021-2032)
- 7.2.2 North America Tolvaptan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Tolvaptan Tablets Revenue (2021-2032)
- 7.3.2 Europe Tolvaptan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Tolvaptan Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Tolvaptan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Tolvaptan Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Tolvaptan Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP
- 8.1.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP Company Information
- 8.1.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP Business Overview
- 8.1.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP Tolvaptan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP Tolvaptan Tablets Product Portfolio
- 8.1.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP Recent Developments
- 8.2 Jiangsu Hengrui Pharmaceuticals
- 8.2.1 Jiangsu Hengrui Pharmaceuticals Company Information
- 8.2.2 Jiangsu Hengrui Pharmaceuticals Business Overview
- 8.2.3 Jiangsu Hengrui Pharmaceuticals Tolvaptan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Jiangsu Hengrui Pharmaceuticals Tolvaptan Tablets Product Portfolio
- 8.2.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
- 8.3 Chengdu Brilliant Pharmaceutical
- 8.3.1 Chengdu Brilliant Pharmaceutical Company Information
- 8.3.2 Chengdu Brilliant Pharmaceutical Business Overview
- 8.3.3 Chengdu Brilliant Pharmaceutical Tolvaptan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Chengdu Brilliant Pharmaceutical Tolvaptan Tablets Product Portfolio
- 8.3.5 Chengdu Brilliant Pharmaceutical Recent Developments
- 8.4 Chengdu Baiyu Pharmaceutical
- 8.4.1 Chengdu Baiyu Pharmaceutical Company Information
- 8.4.2 Chengdu Baiyu Pharmaceutical Business Overview
- 8.4.3 Chengdu Baiyu Pharmaceutical Tolvaptan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Chengdu Baiyu Pharmaceutical Tolvaptan Tablets Product Portfolio
- 8.4.5 Chengdu Baiyu Pharmaceutical Recent Developments
- 8.5 Otsuka Pharmaceutical
- 8.5.1 Otsuka Pharmaceutical Company Information
- 8.5.2 Otsuka Pharmaceutical Business Overview
- 8.5.3 Otsuka Pharmaceutical Tolvaptan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Otsuka Pharmaceutical Tolvaptan Tablets Product Portfolio
- 8.5.5 Otsuka Pharmaceutical Recent Developments
- 8.6 Healing Pharma India
- 8.6.1 Healing Pharma India Company Information
- 8.6.2 Healing Pharma India Business Overview
- 8.6.3 Healing Pharma India Tolvaptan Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Healing Pharma India Tolvaptan Tablets Product Portfolio
- 8.6.5 Healing Pharma India Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Tolvaptan Tablets Value Chain Analysis
- 9.1.1 Tolvaptan Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Tolvaptan Tablets Production Mode & Process
- 9.2 Tolvaptan Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Tolvaptan Tablets Distributors
- 9.2.3 Tolvaptan Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst